La Alborada
Related Articles
DUBLIN – (BUSINESS WIRE) – July 20, 2021–
the “Allergy and Immunology Market Research Report by Allergy Type, Treatment Type, Region – Global Forecast to 2026 – Cumulative Impact of COVID-19” report was added to ResearchAndMarkets.comoffer.
The global allergy and immunology market size was estimated to be $ 2,023.65 million in 2020 and is expected to reach $ 2,250.36 million in 2021, at a compound annual growth rate (CAGR) of 11. 54% to reach $ 3,897.30 million by 2026.
In this report, the years 2018 and 2019 are considered as historical years, 2020 as the base year, 2021 as the estimated year and the years 2022 to 2026 are considered as the forecast period.
Cumulative impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected nearly every industry, and the long-term effects are expected to impact the growth of the industry during the forecast period. This ongoing research amplifies this research framework to ensure the inclusion of the underlying issues of COVID-19 and potential pathways to follow.
The report provides insight on COVID-19 given changes in consumer behavior and demand, purchasing patterns, supply chain diversion, dynamics of current market forces, and significant government interventions. . The updated study provides information, analysis, estimates and forecasts, considering the impact of COVID-19 on the market.
Competitive strategic window:
The Competitive Strategy Window analyzes the competitive landscape in terms of markets, applications and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for suppliers to adopt successive strategies of merger and acquisition, geographic expansion, research and development, and new product introduction strategies to continue the expansion and growth of the business during a forecast period.
FPNV positioning matrix:
The FPNV Positioning Matrix assesses and ranks vendors in the allergy and immunology market based on business strategy (company growth, industry coverage, financial viability, and channel support) and satisfaction (Value for Money, Ease of Use, Product Features and Support) that helps businesses make better decisions and better understand the competitive landscape.
Market share analysis:
The market share analysis offers the analysis of the suppliers considering their contribution to the overall market. It provides the idea of ​​its revenue generation in the overall market compared to other space providers. It provides insight into the performance of vendors in terms of revenue generation and customer base compared to others.
Knowing the market share gives an idea of ​​the size and competitiveness of the suppliers for the base year. It reveals the characteristics of the market in terms of traits of accumulation, fragmentation, dominance and fusion.
Company usability profiles:
The report deeply explores significant recent developments by leading vendors and innovation profiles in the global Allergy and Immunology Market including
- Pharmaceutical company Adamis
- ALK-Abello A / S
- Therapeutic against allergies
- ASIT Biotech
- Circassia
- DBV Technologies SA
- DESENTUM OY
- HAL Allergy BV
- HollisterStier Allergy
- LETIPharma
- Merck KGaA
- Mylan NV
- Stallergenes Greer plc
Main topics covered:
1. Preface
2. Research methodology
3. Executive summary
3.1. introduction
3.2. Market outlook
3.3. Type of allergy
3.4. Distribution channel outlook
3.5. Type of treatment
3.6. Geographic perspectives
3.7. Competitor perspectives
4. Market overview
4.1. introduction
4.2. Cumulative impact of COVID-19
5. Market overview
5.1. Market dynamics
5.1.1. Conductors
5.1.1.1. Growing prevalence of allergic disorders
5.1.1.2. A solid product pipeline for new treatment approaches
5.1.1.3. Advances in sublingual immunotherapy formulations
5.1.2. Constraints
5.1.2.1. Limitation and disadvantage associated with the use of allergen immunotherapy
5.1.3. Opportunities
5.1.3.1. Growing awareness of allergy immunotherapies and rising healthcare costs
5.1.3.2. Extensive R&D for immunotherapy solutions against food allergens
5.1.4. Challenges
5.1.4.1. Lack of awareness of allergy symptoms
5.2. Porters Five Forces Analysis
6. Allergies and Immunology Market, By Allergy Type
6.1. introduction
6.2. Allergic asthma
6.3. Allergic rhinitis
6.4. Food allergy
6.5. Allergy to animals
7. Allergies and Immunology Market, By Distribution Channel
7.1. introduction
7.2. Hospital pharmacy
7.3. Online pharmacy
7.4. Retail pharmacy
8. Allergies and Immunology Market, By Treatment Type
8.1. introduction
8.2. Subcutaneous immunotherapy (SCIT)
8.3. Sublingual immunotherapy (ITSL)
9. US Allergy and Immunology Market
10. Asia-Pacific Allergy and Immunology Market
11. Allergy and Immunology Market in Europe, Middle East and Africa
12. Competitive landscape
12.1. FPNV positioning matrix
12.1.1. Quadrants
12.1.2. Business strategy
12.1.3. Product satisfaction
12.2. Market ranking analysis
12.3. Market share analysis, by key player
12.4. Competitive scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, collaboration and partnership
12.4.3. Launch and improvement of new products
12.4.4. Investment and financing
12.4.5. Awards, recognition and expansion
13. Company usability profiles
For more information on this report, visit https://www.researchandmarkets.com/r/nux5qi
View source version on businesswire.com:https://www.businesswire.com/news/home/20210720005495/en/
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Director
For EST office hours, call 1-917-300-0470
For USA / CAN call toll free 1-800-526-8630
For GMT office hours, call + 353-1-416-8900
KEYWORD:
INDUSTRY KEYWORD: INFECTIOUS DISEASES GENERAL HEALTH PHARMACEUTICAL HEALTH
SOURCE: Research and markets
Copyright Business Wire 2021.
PUB: 07/20/2021 03:42 / DISC: 07/20/2021 03:42
